Russian court upholds Teva antitrust fine
MLex Summary: Russia’s highest court has rejected an appeal by Teva Pharmaceutical Industries against an antitrust fine of 300,000 rubles ($4,890) imposed on the drugmaker for its refusal to supply Copaxane to Biotek....To view the full article, register now.
Already a subscriber? Click here to view full article